Overview
Grix-Blankenship-Peterson syndrome is an extremely rare genetic condition that was first described in the medical literature in the 1980s. This syndrome is now classified as obsolete in some medical databases, meaning it may have been reclassified, merged with another condition, or its original description may have been revised as medical understanding advanced. The condition was originally reported to involve a combination of birth defects affecting multiple body systems, including abnormalities of the growth and development of bones, distinctive facial features, and other congenital malformations. Affected individuals were described as having features such as short stature, limb abnormalities, and craniofacial differences present from birth. Because so few cases have ever been reported in the medical literature, knowledge about this syndrome remains very limited. There is no specific cure or targeted treatment, and management has historically focused on addressing individual symptoms and complications as they arise. Families affected by this condition should work closely with a clinical geneticist to obtain the most current understanding of the diagnosis, as the classification of this syndrome has evolved over time and it may now fall under a different or broader diagnostic category.
Key symptoms:
Short stature or growth delayLimb abnormalitiesUnusual facial featuresBone and skeletal differencesJoint problems or limited joint movementDevelopmental differencesAbnormalities of the hands or feetCraniofacial malformations
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for OBSOLETE: Grix-Blankenship-Peterson syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for OBSOLETE: Grix-Blankenship-Peterson syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for OBSOLETE: Grix-Blankenship-Peterson syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to OBSOLETE: Grix-Blankenship-Peterson syndrome.
Community
No community posts yet. Be the first to share your experience with OBSOLETE: Grix-Blankenship-Peterson syndrome.
Start the conversation →Latest news about OBSOLETE: Grix-Blankenship-Peterson syndrome
No recent news articles for OBSOLETE: Grix-Blankenship-Peterson syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Has this diagnosis been reclassified under a different or more current condition name?,Would whole exome or whole genome sequencing help clarify the genetic cause?,What specialists should be part of my child's care team?,Are there any clinical trials or research studies we could participate in?,What developmental milestones should we watch for, and when should we be concerned?,Are there any complications we should monitor for as my child grows?,Can you connect us with other families or support groups for similar conditions?
Common questions about OBSOLETE: Grix-Blankenship-Peterson syndrome
What is OBSOLETE: Grix-Blankenship-Peterson syndrome?
Grix-Blankenship-Peterson syndrome is an extremely rare genetic condition that was first described in the medical literature in the 1980s. This syndrome is now classified as obsolete in some medical databases, meaning it may have been reclassified, merged with another condition, or its original description may have been revised as medical understanding advanced. The condition was originally reported to involve a combination of birth defects affecting multiple body systems, including abnormalities of the growth and development of bones, distinctive facial features, and other congenital malforma
How is OBSOLETE: Grix-Blankenship-Peterson syndrome inherited?
OBSOLETE: Grix-Blankenship-Peterson syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does OBSOLETE: Grix-Blankenship-Peterson syndrome typically begin?
Typical onset of OBSOLETE: Grix-Blankenship-Peterson syndrome is neonatal. Age of onset can vary across affected individuals.